Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada

BACKGROUND: Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by physicians is of interest. This study aims to examine treatment outcomes of IN...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Infect Dis
Glavni autori: Romanowski, Kamila, Chiang, Leslie Y., Roth, David Z., Krajden, Mel, Tang, Patrick, Cook, Victoria J., Johnston, James C.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5583994/
https://ncbi.nlm.nih.gov/pubmed/28870175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2706-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items